Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

Bibliographic Details
Main Authors: Diego Centonze, Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Luigi Giuliani, Pier Luigi Canonico
Format: Article
Language:English
Published: SEEd Medical Publishers 2018-11-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
cost-effectiveness
peginterferon beta-1a
multiple sclerosis
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1385
id doaj-d8ae94332b85401ea88ccc22534e2c57
record_format Article
spelling doaj-d8ae94332b85401ea88ccc22534e2c572020-11-25T01:12:16ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2018-11-0119110.7175/fe.v19i1.13851262Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated AnalysisDiego Centonze0Sergio Iannazzo1Laura Santoni2Cecilia Saleri3Elisa Puma4Luigi Giuliani5Pier Luigi Canonico6IRCCS Neuromed, Pozzilli (IS), Italy & Laboratory of Synaptic Immunopathology, Tor Vergata University, Rome, ItalySIHS srl, Health Economics Consulting, Turin, ItalyBiogen Italia, Milan, ItalyBiogen Italia, Milan, ItalyBiogen Italia, Milan, ItalySIHS srl, Health Economics Consulting, Turin, ItalyDepartment of Pharmaceutical Sciences, University of Piemonte Orientale “Amedeo Avogadro”, Novara, Italyhttps://journals.seedmedicalpublishers.com/index.php/FE/article/view/1385cost-effectivenesspeginterferon beta-1amultiple sclerosis
collection DOAJ
language English
format Article
sources DOAJ
author Diego Centonze
Sergio Iannazzo
Laura Santoni
Cecilia Saleri
Elisa Puma
Luigi Giuliani
Pier Luigi Canonico
spellingShingle Diego Centonze
Sergio Iannazzo
Laura Santoni
Cecilia Saleri
Elisa Puma
Luigi Giuliani
Pier Luigi Canonico
Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
Farmeconomia: Health Economics and Therapeutic Pathways
cost-effectiveness
peginterferon beta-1a
multiple sclerosis
author_facet Diego Centonze
Sergio Iannazzo
Laura Santoni
Cecilia Saleri
Elisa Puma
Luigi Giuliani
Pier Luigi Canonico
author_sort Diego Centonze
title Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
title_short Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
title_full Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
title_fullStr Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
title_full_unstemmed Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
title_sort cost-effectiveness analysis of peginterferon beta-1a in the treatment of relapsing-remitting multiple sclerosis in italy: results of an updated analysis
publisher SEEd Medical Publishers
series Farmeconomia: Health Economics and Therapeutic Pathways
issn 2240-256X
publishDate 2018-11-01
topic cost-effectiveness
peginterferon beta-1a
multiple sclerosis
url https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1385
work_keys_str_mv AT diegocentonze costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
AT sergioiannazzo costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
AT laurasantoni costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
AT ceciliasaleri costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
AT elisapuma costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
AT luigigiuliani costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
AT pierluigicanonico costeffectivenessanalysisofpeginterferonbeta1ainthetreatmentofrelapsingremittingmultiplesclerosisinitalyresultsofanupdatedanalysis
_version_ 1725167435240177664

Similar Items